Get the Daily Brief
Latest Biotech News
Insmed’s Brensocatib Gains FDA Nod as First Chronic Lung Disease Therapy
Insmed secured FDA approval for Brensocatib (Brinsupri), the first treatment for non-cystic fibrosis bronchiectasis (NCFB). This dipeptidyl peptidase 1 (DPP1) inhibitor targets neutrophilic...
Bayer-Kumquat Team Up on KRAS G12D Inhibitor With $1.3B Potential
Bayer entered an exclusive global license and collaboration agreement with Kumquat Biosciences to develop and commercialize Kumquat’s KRAS G12D inhibitor, a precision oncology asset targeting...
Novartis Clinches Phase III Wins for Autoimmune ianalumab
Novartis announced two positive Phase 3 trial readouts for ianalumab, a monoclonal antibody with dual B-cell depletion and BAFF-R inhibition activities, in Sjögren’s disease and primary immune...
Advances in AI and Multi-Omics Revolutionize Biomarker and Drug Discovery
Cutting-edge artificial intelligence and machine learning applications are accelerating discoveries in cancer biomarker identification and drug combination prediction. Multi-omics integration...
AI-Powered Diagnostics and Imaging Technologies Make Strides
Recent breakthroughs in AI-enhanced diagnostic tools include AI-assisted compact microscopes for cervical precancer screening, AI-enhanced 3D ultrasound imaging for improved resolution, and AI...
Insilico and University Teams Advance Small Enzymes and Gene Editing
Researchers have developed novel AI-based methods to design small enzymes tailored for bioprocessing and pioneered AI-assisted gene editing precision. ProtGPT2, a language model for proteins,...
Emerging Respiratory and Neurodegenerative Therapies Show Promise
Novel therapeutics targeting respiratory and neurodegenerative diseases have gained momentum. Insmed’s first DPP1 inhibitor brensocatib offers a new option for bronchiectasis patients. Meanwhile,...
FDA Regulatory Reforms and Leadership Shakeup Influence Industry
Significant regulatory shifts are underway at the FDA. Vinay Prasad was swiftly reinstated as director of CBER following political controversies, reflecting agency leadership volatility....
Innovations in Cell Therapy Manufacturing and Immune Activation Tools
Collaborations are emerging to scale and optimize cell therapy manufacturing. Sartorius Stedim Biotech partnered with Nanotein Technologies to commercialize NanoSpark soluble activators that...
Cancer Immunotherapy and Vaccine Development Faces Mixed Outcomes
Immunotherapy and cancer vaccines are showing varied clinical results. Pfizer’s antibody-drug conjugate Padcev, combined with Merck’s Keytruda, demonstrated meaningful survival benefits in bladder...
Bayer and Kumquat's $1.3 Billion KRAS Cancer Collaboration
Bayer has entered an exclusive global licensing and collaboration agreement with Kumquat Biosciences to develop and commercialize Kumquat’s investigational KRAS G12D inhibitor. This move targets a...
Insmed’s Brinsupri Approved As First Treatment for Bronchiectasis
Insmed's brensocatib (Brinsupri) has received FDA approval as the first treatment for non-cystic fibrosis bronchiectasis, a chronic lung condition affecting approximately 500,000 Americans....
Novel AI and Machine Learning Advances in Gene Editing
Researchers have integrated artificial intelligence (AI) and deep learning techniques to enhance precision and predictability in gene editing. A study from the University of Zurich introduced...
AI-Powered Tools Transform Cancer Diagnosis and Therapeutics
Artificial intelligence continues to shape oncology by providing improved diagnostics and drug development pathways. The Radiological Society of North America’s AI Challenge showcased models that...
Challenges and Developments in Biopharma Financing and Real Estate
The life sciences sector faces headwinds amid rising real estate vacancies and cooling venture capital (VC) funding, particularly evident in the Greater Boston area where lab space vacancies have...
Breakthroughs in Neurodegenerative Disease Research and Therapies
Recent studies have unveiled novel mechanisms and therapeutic candidates targeting neurodegenerative diseases. Mitochondrial dysfunction's causal role in Alzheimer’s and dementia was countered...
Cancer Vaccine and Immunotherapy Trials Yield Mixed Outcomes
Multiple oncology immunotherapy programs report critical trial updates. IO Biotech's phase 3 trial for the off-the-shelf cancer vaccine Cylembio narrowly missed its primary endpoint when combined...
AI and Digital Health Innovations in Diagnostics and Patient Care
Advancements in artificial intelligence and digital technologies are transforming diagnostics and patient management. Mount Sinai researchers developed AI models predicting hospital admissions...
Regulatory and Industry Shifts Impacting Biotech and Pharma
The biotech and pharmaceutical sectors face significant regulatory and operational developments. The FDA reinstated Vinay Prasad as CBER director amid controversy and political pressures....
Insmed’s Brinsupri Hits Market – New Bronchiectasis Drug Gains FDA Nod
Insmed’s Brinsupri (brensocatib) became the first FDA-approved treatment specifically for non-cystic fibrosis bronchiectasis (NCFB), a chronic lung disorder afflicting approximately 500,000 U.S....